Submacular Hemorrhage

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-04
Clinical Trial Update: Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). [Phase 3]
A Phase 3 clinical trial (TIGER) evaluating vitrectomy with subretinal tissue plasminogen activator and intravitreal gas for submacular hemo…